Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1067
https://www.valueinhealthjournal.com/article/S1098-3015(18)31370-6/fulltext
Title :
Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31370-6&doi=10.1016/j.jval.2018.04.1067
First page :
Section Title :
Open access? :
No
Section Order :
336